CINCINNATI, Jan. 13, 2009 (GLOBE NEWSWIRE) -- Attorney Advertising. The Cincinnati class action law firm of Statman, Harris & Eyrich, LLC announces that a class action lawsuit was filed on Friday, December 12, 2008 in the United States District Court for the Southern District of Ohio, on behalf of investors who purchased the common stock of AtriCure, Inc. ("Company") (Nasdaq:ATRC) between May 10, 2007 and October 31, 2008, inclusive (the "Class Period").
The complaint charges AtriCure and certain of its officers with violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by failing to disclose that AtriCure misrepresented its profitability by, among other things, illegally promoting its products contrary to FDA regulations and filing false claims for Medicare reimbursement. The complaint alleges that defendants issued a series of materially false and misleading statements and SEC filings concerning the Company's operations, finances and performance and that the price of AtriCure common stock to investors was artificially inflated during the Class Period.
If you purchased AtriCure common stock between May 10, 2007 and October 31, 2008, and would like to learn more about these claims, or have any questions concerning this notice or your rights with respect to this matter, please contact Elizabeth L. Hutton, Esq. at (513) 621-2666 or (888) 876-7881, or via e-mail at ehutton@statmanharris.com for further information without any obligation or cost to you.
Statman, Harris & Eyrich, LLC has offices in Chicago, Illinois; Cincinnati, Ohio; Dayton, Ohio; and Sarasota, Florida. www.statmanharris.com